Omni Partners secures debt-raise to support acquisition of Aesthetic Technology

Arrowpoint Advisory’s Debt Advisory team have advised Omni Partners on a debt raise to support its acquisition of Aesthetic Technology Limited (“ATL”).

Founded in 2012, ATL is a multi-award-winning LED phototherapy company specialising in the development of innovative energy-based devices for the medical, aesthetic and cosmetic markets. ATL is the manufacturer of Dermalux LED systems, a unique breakthrough technology that delivers advanced treatment of skin conditions through the optimisation of three clinically proven combined wavelengths.

The financing was provided by ThinCats and Tosca Debt Capital.

Charles Gallagher-Powell, Partner and Head of Private Equity at Omni Partners, said: “It has been a real pleasure to work with Arrowpoint Advisory, who have been tireless in their pursuit of our targeted financing package. We are delighted to have secured this with ThinCats and Tosca Debt Capital as we support ATL with its ambitious growth plans.”

Randal Pringle, Director at Arrowpoint Advisory, added: “We are delighted to have worked with Omni Partners to secure a highly commercial and flexible financing package to support their investment in ATL. It was a pleasure to work with ThinCats and Tosca Debt Capital and we look forward to seeing ATL continue to flourish in its partnership with Omni.”

Contact the deal team